The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines that are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, the smart and flexible design of clinical trials, and evolving regulatory science to speed up vaccine development against Covid-19 and transform vaccine development altogether.
Keywords: Adjuvants; COVID-19; Human genetics; Machine learning; Platform technologies; Real world evidence; Regulatory convergence; Smart clinical trials; Systems biology; Vaccine; Vaccine development; Vaccine discovery; Vaccines safety.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.